LEVENT DOĞANAY et al. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology, [S. l.], v. 31, n. 12, p. 883–893, 2021. Disponível em: https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/3971. Acesso em: 6 jul. 2025.